Identification
- Composition (DCI)
- epirubicine
- Manufacturer
- SYNTHEMEDIC
- ATC code
- L01DB03
- Presentation
- 1 flacon
- Schedule / Reimb.
- A
- Hospital price
- 216.00 MAD
Indications
Traitement adjuvant du carcinome mammaire au stade précoce. Traitement du carcinome mammaire au stade avancé. Traitement du/des lymphomes malins, sarcome des parties molles, carcinome de l'estomac, carcinome bronchique, carcinome de l'ovaire. Instillation intravésicale pour traiter et prévenir les récidives de papillomatoses carcinomateuses vésicales superficielles après résection transurétrale.
Find an open pharmacy
On-call pharmacies near you
About EPIRUBICINE MYLAN 2 MG / ML
EPIRUBICINE MYLAN 2 MG / ML is marketed in Morocco by SYNTHEMEDIC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of EPIRUBICINE MYLAN 2 MG / ML, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about EPIRUBICINE MYLAN 2 MG / ML
Answers to common questions from Moroccan patients about this drug.